PIK3CA has no role in the aggressive behavior of CRC, yet, when it occurs concurrently with KRAS mutations, evident aggressive behavior will be apparent, especially when it involves exons 9 or 20 or both [31, 32]. This evidence concerns the gene KRAS and colorectal carcinoma.